NewsRx

Search our medical news database

Interface, Inc.

Interface, Inc. Announces Extension of Early Tender Deadline in Tender Offer

Published in Law and Health Weekly, June 13th, 2009

Interface, Inc. (NASDAQ:IFSIA) (the "Company") announced that it is extending the deadline (the "Early Tender Deadline") for holders of its 10.375% Senior Notes due 2010 (the "Notes") (CUSIP No. 458665AG1) to tender their Notes and receive the total consideration of $1,045 per $1,000 principal amount of Notes, which includes the early tender payment of $30 per $1,000 principal amount of Notes, to 5:00 P.M., Eastern Time, on May 29, 2009. As previously announced, the Company is offering to purchase any and all of the Notes (the "Offer"). Early payment is expected to be made for Notes tendered by the Early Tender Deadline on the date that the conditions to the Offer are met or waived. The...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook